Knut Krohn Selected Research

Knut Krohn Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 05/2007
6	Thyroid Nodule (Nodule, Thyroid) 10/2020 - 03/2002
6	Thyroid Neoplasms (Thyroid Cancer) 11/2016 - 10/2005
3	Atherosclerosis 01/2022 - 01/2016
3	Insulin Resistance 01/2022 - 04/2005
3	Inflammation (Inflammations) 01/2020 - 10/2015
3	Adenoma (Adenomas) 11/2016 - 06/2003
3	Follicular Adenocarcinoma 11/2016 - 03/2014
2	Overweight 01/2020 - 11/2018
2	Breast Neoplasms (Breast Cancer) 09/2019 - 11/2013
2	Obesity 11/2018 - 08/2015
2	Type 2 Diabetes Mellitus (MODY) 11/2018 - 02/2010
2	follicular Thyroid cancer 03/2014 - 03/2010
2	Hyperplasia 11/2011 - 03/2002
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2005 - 03/2003
1	COVID-19 06/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Abdominal Obesity 01/2022
1	Melanoma (Melanoma, Malignant) 10/2021
1	Sepsis (Septicemia) 09/2020
1	Rheumatoid Arthritis 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Microcephaly 01/2018
1	Transient Ischemic Attack 09/2017
1	Ischemic Stroke 09/2017
1	Hypoxia (Hypoxemia) 09/2017
1	Stroke (Strokes) 09/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2015
1	Squamous Cell Carcinoma of Head and Neck 12/2015
1	Lymphatic Metastasis 12/2015
1	Weight Loss (Weight Reduction) 10/2015
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 09/2015
1	Metabolic Diseases (Metabolic Disease) 09/2015
1	Hypersensitivity (Allergy) 07/2015
1	Vascular Diseases (Vascular Disease) 07/2015
1	Sleep Wake Disorders 07/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Body Weight (Weight, Body) 10/2014
1	Pancreatitis 01/2012
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2012
1	Chronic Pancreatitis 01/2012

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2014
6	Thyrotropin Receptors (Thyrotropin Receptor)IBA 10/2020 - 03/2002
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
5	RNA (Ribonucleic Acid)IBA 10/2021 - 12/2015
4	IodineIBA 02/2011 - 03/2002
3	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 02/2010
2	Insulin (Novolin)FDA Link 01/2022 - 11/2018
2	Heme (Haem)IBA 01/2020 - 01/2012
2	Amino Acids FDA Link 09/2019 - 09/2015
2	Small Interfering RNA (siRNA)IBA 09/2019 - 03/2010
2	Messenger RNA (mRNA)IBA 11/2018 - 10/2014
2	EnzymesIBA 01/2018 - 11/2013
2	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 01/2012
2	Genetic Markers (Genetic Marker)IBA 07/2015 - 05/2007
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 01/2004
2	Imatinib Mesylate (Gleevec)FDA Link 04/2005 - 03/2003
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	trametinibIBA 10/2021
1	cobimetinibIBA 10/2021
1	VemurafenibIBA 10/2021
1	Carrier Proteins (Binding Protein)IBA 10/2020
1	Guanine NucleotidesIBA 10/2020
1	ElementsIBA 09/2020
1	InflammasomesIBA 01/2020
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2020
1	Calcium-Sensing ReceptorsIBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 09/2019
1	Odorant Receptors (Odorant Receptor)IBA 11/2018
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2018
1	ProgranulinsIBA 01/2018
1	LDL Receptors (LDL Receptor)IBA 10/2017
1	Phospholipases (Phospholipase)IBA 10/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2017
1	Untranslated RNA (Noncoding RNA)IBA 01/2016
1	Ribosomal RNAIBA 01/2016
1	Branched-Chain Amino AcidsIBA 10/2015
1	NAD (NADH)IBA 10/2015
1	Glutathione (Reduced Glutathione)IBA 10/2015
1	HDL CholesterolIBA 08/2015
1	Retinaldehyde (Retinal)IBA 07/2015
1	Triglycerides (Triacylglycerol)IBA 10/2014
1	LipidsIBA 10/2014
1	diglycerol phosphateIBA 11/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2013
1	Pantothenic Acid (Calcium Pantothenate)FDA Link 11/2013
1	beta-AlanineIBA 11/2013
1	Heme Oxygenase-1IBA 01/2012
1	Carbon MonoxideIBA 01/2012
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2019
1	Critical Care (Surgical Intensive Care) 09/2020
1	Bariatric Surgery 10/2015